Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR) [Phase 2]
A Phase 2 study assessed the efficacy and safety of the fixed-dose combination nasal spray olopatadine hydrochloride and mometasone furoate …
-
FDA approval · 2018-05-18FDA Approved: MONTELUKAST — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for montelukast submitted by BluePoint Laboratories under ANDA 203366. The decision denotes appr…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis [Phase 4]
Phase 4 clinical trial update evaluating Fluticasone Furoate for daytime somnolence and cognitive performance in seasonal allergic rhinitis;…
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis [Phase 2]
Phase 2 trial evaluating the combination of S-555739 and cetirizine hydrochloride in adults with seasonal allergic rhinitis has completed.
-
FDA approval · 2018-04-18FDA Approved: CLARITIN LIQUI-GELS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Claritin Liqui-Gels (loratadine) as a new dosage form in the Claritin product line, manufactu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR) [Phase 3]
Phase 3 trial results report on the efficacy and safety of GSP 301 nasal spray for seasonal allergic rhinitis. The study results were posted…
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine [Phase 4]
Phase 4 trial comparing intranasal fluticasone furoate to oral fexofenadine for seasonal allergic rhinitis; the study completed and results …
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosing Schemes for a Sublingual Immunotherapy Treatment
A completed non-interventional study assessing tolerability, safety, and adherence of different up-dosing regimens for a sublingual immunoth…
-
FDA approval · 2017-09-18FDA Approved: XHANCE — Original Application (OptiNose US, Inc.)
The FDA approved XHANCE, a new intranasal spray formulation of fluticasone propionate from OptiNose US, Inc., under an original NDA for trea…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Investigation Of a New Oral Anti-Histamine in Healthy Male Subjects [Phase 1]
Phase 1 update on an investigational oral antihistamine tested in healthy male volunteers. The trial addresses allergic rhinitis, including …
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects [Phase 1]
Phase 1 first-in-human study of an intranasal H1/H3 dual antagonist in healthy male volunteers, evaluating single and repeat-dose administra…
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: 723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover [Phase 2]
Phase 2 proof-of-concept study in an allergen challenge chamber for seasonal allergic rhinitis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: To Study GSP 301 in Patients With Seasonal Allergic Rhinitis [Phase 2]
Phase 2 study of GSP 301 in seasonal allergic rhinitis completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics. [Phase 1]
A Phase 1 study assessing safety, tolerability, PK and PD of GSK2245035 in healthy volunteers and individuals with seasonal allergic rhiniti…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Pilot Study to Evaluate Ear Acupressure Effects in Treating Seasonal Allergic Rhinitis [NA]
This pilot trial evaluated ear acupressure for seasonal allergic rhinitis and was terminated. Results have been posted (2017-06-27).
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Long-Term Effects of Sublingual Grass Therapy [Phase 2]
Phase 2 trial evaluating the long-term safety and effects of sublingual grass pollen immunotherapy for seasonal allergic rhinitis.
-
CLINICAL_TRIALS research · 2017-05-30Clinical Trial Update: Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting
A prospective observational study examining concomitant treatment patterns for allergic rhinitis among patients starting fluticasone furoate…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine [Phase 1]
A Phase 1 study assessing the relative bioavailability of intranasal fluticasone furoate and levocabastine has been completed. The trial inv…
-
FDA approval · 2017-04-28FDA Approved: AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE — Original Application (Apotex Corp.)
FDA approves Apotex's original application for a generic nasal spray combining azelastine hydrochloride with fluticasone propionate for alle…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) [Phase 4]
Phase 4 randomized, double-blind, parallel-group, placebo-controlled trial evaluating cetirizine HCl syrup and loratadine syrup against plac…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648) [Phase 3]
Phase 3 safety and efficacy trial of epinastine nasal spray in seasonal allergic rhinitis completed.
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance [Phase 2]
This update reports the completion of a Phase 2 study evaluating VAK694 in combination with allergen immunotherapy to induce specific immune…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure Unit [NA]
Completed clinical trial evaluating pollen starch granules in pollen challenge studies at the Fraunhofer Environmental Exposure Unit for ast…
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis [Phase 1, Phase 2]
Phase 1/2 trial evaluating Nasapaque Nasal Solution for efficacy and safety in adults with seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR) [Phase 3]
Phase 3 trial update on a once-daily investigational nasal spray for seasonal allergic rhinitis in adults and adolescents; the study has com…